PlainRecalls
FDA Drug Moderate Class II Terminated

Midazolam in 0.9% Sodium Chloride Injection, 50 mg per 50 mL (1 mg per mL), Rx only, SterRx, 141 Idaho Ave. Plattsburgh, NY 12003, NDC #70324-102-01.

Reported: January 5, 2022 Initiated: November 12, 2021 #D-0300-2022

Product Description

Midazolam in 0.9% Sodium Chloride Injection, 50 mg per 50 mL (1 mg per mL), Rx only, SterRx, 141 Idaho Ave. Plattsburgh, NY 12003, NDC #70324-102-01.

Reason for Recall

Lack of Assurance of Sterility

Details

Recalling Firm
SterRx, LLC
Units Affected
15660 bags
Distribution
U.S.A. Nationwide
Location
Plattsburgh, NY

Frequently Asked Questions

What product was recalled?
Midazolam in 0.9% Sodium Chloride Injection, 50 mg per 50 mL (1 mg per mL), Rx only, SterRx, 141 Idaho Ave. Plattsburgh, NY 12003, NDC #70324-102-01.. Recalled by SterRx, LLC. Units affected: 15660 bags.
Why was this product recalled?
Lack of Assurance of Sterility
Which agency issued this recall?
This recall was issued by the FDA Drug on January 5, 2022. Severity: Moderate. Recall number: D-0300-2022.